Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts

Expanding Sequencing Applications using Target Enrichment and Application to Complex Diseases Research

Dr Emily Leproust, Agilent Technologies, speaking at Next-Gen Sequencing Europe 2011.
Date Posted: Friday, March 16, 2012
Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Related Content

Agilent Announces New CEO Mike McMullen
McMullen elected as chief executive officer by Company’s board of directors.
Thursday, March 19, 2015
Agilent Names Alacris Theranostics as Certified Provider of Target Enrichment Services
Customers receive consistent data quality, reproducibility and reliability.
Saturday, January 17, 2015
Agilent Reports Fourth-Quarter Results
Agilent Technologies reported orders up 4 percent over one year ago to $1.83 billion with revenues of $1.72 billion, down 3 percent compared with one year ago.
Monday, November 18, 2013
Agilent Names Massachusetts Eye and Ear Infirmary as Certified Service Provider for NGS and aCGH Solutions
MEEI's Department of Ophthalmology Ocular Genomics Institute is working to harness the power of genomics and gene therapy to advance the knowledge and treatment of blinding eye diseases.
Thursday, October 24, 2013
Agilent Technologies Teams with University of Liverpool's Centre for Genomic Research
Centre for Genomic Research has become the UK's first Certified Service Provider for the Agilent SureSelect Target Enrichment System for next-generation sequencing.
Wednesday, August 08, 2012
Agilent Names University of Liverpool’s CGR as Certified Service Provider
CGR achieves certified status for Agilent SureSelect target enrichment system for next-generation sequencing.
Monday, July 23, 2012
Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
Project also seeks to develop better tools to test truth of seafood labels.
Monday, March 26, 2012
Agilent Technologies’ Exome Target-Enrichment System to Analyze 1,500 Samples in Erasmus Genetic Population Study
Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part to identify genetic risk factors for some complex genetic disorders.
Thursday, March 08, 2012
Agilent Technologies and BGI to Collaborate
Companies announce a collaborative effort to develop methodologies designated for next-generation genome-wide association studies. The methodologies will assist scientists pursuing disease and drug research.
Wednesday, February 29, 2012
Agilent Picks Up Halo Genomics and BioSystem Development
The technologies company is expanding its life sciences business through the acquisition. Halo Genomics provides sample preparation technology for next-generation DNA sequencing, and BioSystem Development develops and manufactures sample prep solutions for drug R&D.
Monday, December 05, 2011
Scientific News
First Atlas Of Airborne Microbes Across US
Bacteria and fungal species were identified from outdoor dust samples collected from all 50 states.
Genetic Code Of Upland Cotton Cracked
Scientists decode the genetic makeup of upland cotton.
Tumor-Only Genetic Sequencing May Misguide Cancer Treatment in Nearly Half of All Patients
Johns Hopkins scientists say the genetic code of tumors must be compared to patients’ noncancer genome to get a true picture.
Genetic Link For Rare Intestinal Cancer
Researchers recommend screening for people with family history.
Tumor DNA in Blood Reveals Lymphoma Progression
Using an advanced genetic test, researchers were able to detect diffuse large B-cell lymphoma (DLBCL) in blood serum before it could be seen on CT scans.
Likely Genetic Source Of Muscle Weakness Found
Simple genetic test by TGen reveals likely causes of disease, after other extensive testing failed; one child’s case produces discovery.
Mountain Gorillas Enter The Genomic Age
First in-depth analysis reveals genetic impact of long-term population decline.
Personalized Melanoma Vaccines Marshal Powerful Immune Response
Vaccines target unique mutations in each patient’s tumor.
Cell Powerhouse Sequencing Technology Provides Deeper Look at Inherited Disease Risk
A new sequencing technique may provide a clearer picture of how genes in mitochondria, the “powerhouses” that turn sugar into energy in human cells, shape each person’s inherited risk for diabetes, heart disease and cancer.
Genome Study Predicts DNA of the Whole of Iceland
Large genome databases are starting to reveal critical health information-even about people who have not contributed their DNA.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters